Eye Study Is a Small but Crucial Advance for Stem-Cell Therapy

Robert Lanza, chief scientific officer of Advanced Cell Technology. Advanced Cell Technology Eye Study Is a Small but Crucial Advance for Stem-Cell Therapy The results show that the treatment can be safe, but whether it can be effective is another question

More:
Eye Study Is a Small but Crucial Advance for Stem-Cell Therapy